Pfizer Operating Margin 1986-2025 | PFE
Current and historical operating margin for Pfizer (PFE) over the last 10 years. The current operating profit margin for Pfizer as of June 30, 2025 is 35.41%.
| Pfizer Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2025-06-30 |
$63.83B |
$14.83B |
23.23% |
| 2025-03-31 |
$62.46B |
$12.05B |
19.29% |
| 2024-12-31 |
$63.63B |
$12.41B |
19.51% |
| 2024-09-30 |
$60.43B |
$5.78B |
9.56% |
| 2024-06-30 |
$56.22B |
$-2.35B |
-4.19% |
| 2024-03-31 |
$55.95B |
$-1.16B |
-2.08% |
| 2023-12-31 |
$59.55B |
$1.28B |
2.15% |
| 2023-09-30 |
$70.12B |
$10.79B |
15.39% |
| 2023-06-30 |
$79.27B |
$22.91B |
28.90% |
| 2023-03-31 |
$94.00B |
$32.93B |
35.03% |
| 2022-12-31 |
$101.18B |
$35.79B |
35.37% |
| 2022-09-30 |
$99.88B |
$33.55B |
33.59% |
| 2022-06-30 |
$101.28B |
$30.76B |
30.37% |
| 2022-03-31 |
$92.43B |
$24.15B |
26.12% |
| 2021-12-31 |
$81.29B |
$19.43B |
23.91% |
| 2021-09-30 |
$68.88B |
$17.15B |
24.89% |
| 2021-06-30 |
$55.12B |
$13.45B |
24.39% |
| 2021-03-31 |
$46.08B |
$9.91B |
21.51% |
| 2020-12-31 |
$41.65B |
$8.25B |
19.81% |
| 2020-09-30 |
$32.07B |
$2.62B |
8.17% |
| 2020-06-30 |
$34.47B |
$3.13B |
9.08% |
| 2020-03-31 |
$37.87B |
$5.32B |
14.06% |
| 2019-12-31 |
$40.91B |
$6.71B |
16.40% |
| 2019-09-30 |
$40.22B |
$5.62B |
13.98% |
| 2019-06-30 |
$40.84B |
$6.43B |
15.74% |
| 2019-03-31 |
$41.04B |
$6.14B |
14.95% |
| 2018-12-31 |
$40.83B |
$5.67B |
13.89% |
| 2018-09-30 |
$53.37B |
$14.00B |
26.22% |
| 2018-06-30 |
$53.24B |
$13.90B |
26.10% |
| 2018-03-31 |
$52.67B |
$13.66B |
25.94% |
| 2017-12-31 |
$52.55B |
$13.72B |
26.11% |
| 2017-09-30 |
$52.47B |
$13.17B |
25.10% |
| 2017-06-30 |
$52.35B |
$12.53B |
23.93% |
| 2017-03-31 |
$52.60B |
$12.26B |
23.32% |
| 2016-12-31 |
$52.82B |
$12.15B |
22.99% |
| 2016-09-30 |
$53.24B |
$12.22B |
22.96% |
| 2016-06-30 |
$52.29B |
$12.56B |
24.02% |
| 2016-03-31 |
$50.99B |
$12.68B |
24.86% |
| 2015-12-31 |
$48.85B |
$11.82B |
24.20% |
| 2015-09-30 |
$47.92B |
$12.14B |
25.33% |
| 2015-06-30 |
$48.20B |
$12.46B |
25.85% |
| 2015-03-31 |
$49.12B |
$12.82B |
26.09% |
| 2014-12-31 |
$49.61B |
$13.25B |
26.71% |
| 2014-09-30 |
$50.05B |
$14.15B |
28.26% |
| 2014-06-30 |
$50.33B |
$14.45B |
28.71% |
| 2014-03-31 |
$50.53B |
$14.78B |
29.26% |
| 2013-12-31 |
$51.58B |
$15.18B |
29.44% |
| 2013-09-30 |
$50.88B |
$14.70B |
28.90% |
| 2013-06-30 |
$51.19B |
$14.46B |
28.25% |
| 2013-03-31 |
$52.18B |
$15.04B |
28.82% |
| 2012-12-31 |
$54.66B |
$15.26B |
27.93% |
| 2012-09-30 |
$53.25B |
$14.62B |
27.45% |
| 2012-06-30 |
$56.90B |
$14.96B |
26.29% |
| 2012-03-31 |
$59.42B |
$14.12B |
23.76% |
| 2011-12-31 |
$61.04B |
$13.97B |
22.88% |
| 2011-09-30 |
$65.06B |
$13.94B |
21.43% |
| 2011-06-30 |
$64.44B |
$13.62B |
21.13% |
| 2011-03-31 |
$65.09B |
$13.80B |
21.19% |
| 2010-12-31 |
$65.17B |
$13.41B |
20.58% |
| 2010-09-30 |
$65.50B |
$11.49B |
17.54% |
| 2010-06-30 |
$61.13B |
$11.85B |
19.39% |
| 2010-03-31 |
$54.98B |
$10.77B |
19.60% |
| 2009-12-31 |
$49.27B |
$10.96B |
22.24% |
| 2009-09-30 |
$45.82B |
$13.43B |
29.32% |
| 2009-06-30 |
$46.17B |
$12.75B |
27.61% |
| 2009-03-31 |
$47.32B |
$12.25B |
25.89% |
| 2008-12-31 |
$48.30B |
$11.73B |
24.28% |
| 2008-09-30 |
$48.82B |
$11.65B |
23.86% |
| 2008-06-30 |
$48.84B |
$8.58B |
17.57% |
| 2008-03-31 |
$47.79B |
$7.09B |
14.84% |
| 2007-12-31 |
$48.42B |
$7.52B |
15.53% |
| 2007-09-30 |
$48.15B |
$6.93B |
14.39% |
| 2007-06-30 |
$48.44B |
$10.17B |
20.99% |
| 2007-03-31 |
$49.10B |
$11.76B |
23.95% |
| 2006-12-31 |
$48.37B |
$12.12B |
25.06% |
| 2006-09-30 |
$47.37B |
$13.03B |
27.51% |
| 2006-06-30 |
$46.35B |
$11.27B |
24.32% |
| 2006-03-31 |
$46.06B |
$11.26B |
24.45% |
| 2005-12-31 |
$47.41B |
$11.20B |
23.62% |
| 2005-09-30 |
$47.20B |
$12.08B |
25.60% |
| 2005-06-30 |
$48.77B |
$14.46B |
29.64% |
| 2005-03-31 |
$49.59B |
$15.07B |
30.38% |
| 2004-12-31 |
$48.99B |
$14.21B |
29.00% |
| 2004-09-30 |
$51.57B |
$12.68B |
24.59% |
| 2004-06-30 |
$51.09B |
$10.82B |
21.17% |
| 2004-03-31 |
$48.72B |
$3.94B |
8.09% |
| 2003-12-31 |
$44.74B |
$4.26B |
9.51% |
| 2003-09-30 |
$40.01B |
$5.56B |
13.89% |
| 2003-06-30 |
$35.66B |
$6.14B |
17.22% |
| 2003-03-31 |
$33.05B |
$12.02B |
36.36% |
| 2002-12-31 |
$32.29B |
$11.59B |
35.89% |
| 2002-09-30 |
$29.03B |
$10.45B |
35.99% |
| 2002-06-30 |
$28.86B |
$10.24B |
35.49% |
| 2002-03-31 |
$29.19B |
$10.32B |
35.35% |
| 2001-12-31 |
$29.02B |
$9.89B |
34.07% |
| 2001-09-30 |
$31.14B |
$7.92B |
25.42% |
| 2001-06-30 |
$30.47B |
$6.92B |
22.72% |
| 2001-03-31 |
$29.84B |
$5.99B |
20.07% |
| 2000-12-31 |
$29.41B |
$3.74B |
12.71% |
| 2000-09-30 |
$25.81B |
$4.82B |
18.68% |
| 2000-06-30 |
$21.99B |
$3.42B |
15.56% |
| 2000-03-31 |
$18.78B |
$3.02B |
16.11% |
| 1999-12-31 |
$15.54B |
$3.89B |
25.01% |
| 1999-09-30 |
$14.90B |
$3.90B |
26.14% |
| 1999-06-30 |
$14.90B |
$4.52B |
30.36% |
| 1999-03-31 |
$14.24B |
$3.91B |
27.44% |
| 1998-12-31 |
$13.35B |
$3.41B |
25.51% |
| 1998-09-30 |
$12.39B |
$2.41B |
19.42% |
| 1998-06-30 |
$11.71B |
$1.87B |
15.93% |
| 1998-03-31 |
$11.09B |
$1.69B |
15.22% |
| 1997-12-31 |
$10.74B |
$1.58B |
14.72% |
| 1997-09-30 |
$10.99B |
$1.79B |
16.30% |
| 1997-06-30 |
$11.14B |
$2.18B |
19.59% |
| 1997-03-31 |
$11.31B |
$2.54B |
22.48% |
| 1996-12-31 |
$11.31B |
$2.80B |
24.80% |
| 1996-09-30 |
$10.89B |
$2.83B |
25.96% |
| 1996-06-30 |
$10.63B |
$2.68B |
25.25% |
| 1996-03-31 |
$10.37B |
$2.50B |
24.15% |
| 1995-12-31 |
$10.02B |
$2.30B |
22.94% |
| 1995-09-30 |
$9.58B |
$2.25B |
23.53% |
| 1995-06-30 |
$9.11B |
$2.07B |
22.71% |
| 1995-03-31 |
$8.64B |
$2.01B |
23.30% |
| 1994-12-31 |
$8.28B |
$1.97B |
23.83% |
| 1994-09-30 |
$7.97B |
$1.88B |
23.54% |
| 1994-06-30 |
$7.77B |
$1.82B |
23.39% |
| 1994-03-31 |
$7.59B |
$1.74B |
22.95% |
| 1993-12-31 |
$7.48B |
$1.67B |
22.27% |
| 1993-09-30 |
$7.44B |
$1.62B |
21.73% |
| 1993-06-30 |
$7.39B |
$1.57B |
21.26% |
| 1993-03-31 |
$7.34B |
$1.52B |
20.75% |
| 1992-12-31 |
$7.23B |
$1.44B |
19.96% |
| 1992-09-30 |
$7.13B |
$1.35B |
18.88% |
| 1992-06-30 |
$7.08B |
$1.32B |
18.61% |
| 1992-03-31 |
$7.02B |
$1.29B |
18.39% |
| 1991-12-31 |
$6.95B |
$1.25B |
18.04% |
| 1991-09-30 |
$6.89B |
$1.20B |
17.49% |
| 1991-06-30 |
$6.76B |
$1.16B |
17.17% |
| 1991-03-31 |
$6.62B |
$1.12B |
16.95% |
| 1990-12-31 |
$6.41B |
$1.05B |
16.45% |
| 1990-09-30 |
$6.12B |
$1.02B |
16.60% |
| 1990-06-30 |
$5.91B |
$0.98B |
16.60% |
| 1990-03-31 |
$5.72B |
$0.95B |
16.61% |
| 1989-12-31 |
$5.67B |
$0.97B |
17.07% |
| 1989-09-30 |
$5.55B |
$0.97B |
17.44% |
| 1989-06-30 |
$5.49B |
$0.97B |
17.69% |
| 1989-03-31 |
$5.52B |
$1.05B |
19.05% |
| 1988-12-31 |
$5.39B |
$1.01B |
18.77% |
| 1988-09-30 |
$5.29B |
$1.01B |
19.01% |
| 1988-06-30 |
$5.21B |
$0.99B |
19.03% |
| 1988-03-31 |
$5.10B |
$0.99B |
19.40% |
| 1987-12-31 |
$4.92B |
$0.94B |
19.11% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$201.199B |
$100.330B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
